Literature DB >> 18566166

When is the right time to conduct a clinical trial of a diagnostic imaging technology?

Bruce J Hillman, Constantine A Gatsonis.   

Abstract

Mesh：

Year:  2008        PMID： 18566166     DOI： 10.1148/radiol.2481072190

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  5 in total

Review 1.  A review of imaging agent development.

Authors:  Eric D Agdeppa; Mary E Spilker
Journal:  AAPS J       Date:  2009-05-05       Impact factor: 4.009

2.  Evidence-based radiology: why and how?

Authors:  Francesco Sardanelli; Myriam G Hunink; Fiona J Gilbert; Giovanni Di Leo; Gabriel P Krestin
Journal:  Eur Radiol       Date:  2010-01       Impact factor: 5.315

3.  Practice-based evidence for the clinical benefit of PET/CT-results of the first oncologic PET/CT registry in Germany.

Authors:  Christina Pfannenberg; Brigitte Gueckel; Lisa Wang; Sergios Gatidis; Susann-Cathrin Olthof; Werner Vach; Matthias Reimold; Christian la Fougere; Konstantin Nikolaou; Peter Martus
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-29       Impact factor: 9.236

Review 4.  Beyond Correlations, Sensitivities, and Specificities: A Roadmap for Demonstrating Utility of Advanced Imaging in Oncology Treatment and Clinical Trial Design.

Authors:  Erich P Huang; Frank I Lin; Lalitha K Shankar
Journal:  Acad Radiol       Date:  2017-04-26       Impact factor: 3.173

5.  Characterization of a murine xenograft model for contrast agent development in breast lesion malignancy assessment.

Authors:  Tsung-Hsien Yen; Gi-Da Lee; Jyn-Wen Chai; Jiunn-Wang Liao; Jia-Yu Lau; Li-Che Hu; Kuo-Chih Liao
Journal:  J Biomed Sci       Date:  2016-05-17       Impact factor: 8.410
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.